Thursday, January 12, 2023

California is latest state to sue drug companies over high insulin prices - MarketWatch

No comments:

Post a Comment

Companies' reluctance to roll back price rises poses US inflation risk - Financial Times

[unable to retrieve full-text content] Companies' reluctance to roll back price rises poses US inflation risk    Financial Times from...